We are pleased to share that Dr. Andrew Clarke has been appointed Adjunct Associate Professor of the University of Queensland in the School of Chemistry and Molecular Biosciences. The appointment will initially be for a three-year period commencing 1 January 2025 to 31 December 2027.
Passionate about the biotechnology industry (particularly the biomedical research sector) Dr. Andrew Clarke heads James & Wells’ biotechnology patents team in Australia. Andrew has an impressive track record of managing and prosecuting worldwide portfolios for universities, large research organisations, ASX-listed companies, and start-ups. He is regularly involved in research and government lobbying projects for global industry organisations such as the International Association for the Protection of Intellectual Property (AIPPI). Andrew lectures both undergraduate and postgraduate biotechnology students at the University of Queensland on all areas of intellectual property relevant to the biotechnology industry.
The University of Queensland and particularly the School of Chemistry and Molecular Biosciences is a leading international powerhouse of teaching and research in the life sciences field.
